Form 4 for TARS Tarsus Pharmaceuticals, Inc.
Accepted 2026-06-17 16:17:18 ET · period of report 2026-06-15 · accession 0002044770-26-000006 · SEC index · Original document
Summary rows
Aggregated the way they appear in lists: one row per insider, transaction code and security table.
| X | Filed | Traded | Ticker | Insider | Title | Type | Price | Qty | Owned | ΔOwn | Value |
|---|---|---|---|---|---|---|---|---|---|---|---|
| T | 2026-06-17 16:17 | 2026-06-15 | TARS | Goodrich Katherine | Dir | S - Sale | $62.08 | -2,954 | 2,233 | -57% | -$183.4K |
Purchase Sale Sale after option exercise All abbreviations
Every reported transaction
| # | Table | Security | Date | Code | A/D | Shares | Price | Owned after | Own | Exercise / expiry | Underlying | Footnotes |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 1 | Common | Common Stock | 2026-06-15 | S | D | 2,954 | $62.08 | 2,233 | D | — | — | (F1) The sales reported in this Form 4 were effected by an automatic sale pursuant to a Rule 10b5-1 trading plan adopted by the Reporting Person on February 27, 2026. |